Dan Cowell


Daniel has spent the past 18 years leading the commercial, and scientific direction of various UK based biotechnology companies, in fields ranging from oncology to translational genomics research. He has previously co-founded the companies Pharmorphix, a drug discovery company which was subsequently acquired by Sigma Aldrich, and Hypoxium, a com...


Roles at Psyomics

  • CEO

    Current role

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.